Screening Cardiovascular Patients for Aortic aNeurysms (SCAN)
SCAN
1 other identifier
observational
1,000
1 country
2
Brief Summary
The aim of the cohort study SCAN (Screening Cardiovascular patients for Aortic aNeurysms) is to establish a screening programm for patients with a high risk for an AAA. Aortic aneurysms in these patients should be identified at an early stage and thereby AAA-associated mortality be decreased.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2014
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 12, 2014
CompletedFirst Posted
Study publicly available on registry
July 2, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedJanuary 6, 2017
January 1, 2017
3.8 years
June 12, 2014
January 5, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of AAA
Ultrasound screen for the presence of an AAA
1 year
Secondary Outcomes (4)
Prevalence of AAA in the cohort requiring treatment
1 year
Correlation of risk factors for AAA with risk factors for coronary artery disease
1 year
Distribution of risk factors
1 year
Correlation of the number of treated vessels and AAA
1 year
Eligibility Criteria
Men with coronary artery intervention (PTCA/stenting) and at least 1 risk factor for AAA (hypertension, hyperlipidaemia, hyperuricemia, nicotine abuse,positive family history.
You may qualify if:
- men with coronary artery intervention (PTCA/stenting)
- at least 1 risk factor for AAA (hypertension, hyperlipidaemia, hyperuricemia, nicotine abuse,positive family history)
You may not qualify if:
- life expectancy less than 1 year
- inability to follow the instructions of the investigator (dementia, lack of time, insufficient understanding of the language)
- insufficient compliance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Klinikum rechts der Isar, Klinik und Poliklinik für Vaskuläre und Endovaskuläre Chirurgie
Munich, Bavaria, 81675, Germany
I. Medizinischen Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München
München, Bavaria, 81675, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hans-Henning Eckstein, Univ.-Prof.Dr.med.
Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar der Technische Universität München
- PRINCIPAL INVESTIGATOR
Karl-Ludwig Laugwitz, Univ.-Prof.Dr.med.
I. Medizinischen Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Univ.-Prof. Dr. med. Hans-Henning Eckstein
Study Record Dates
First Submitted
June 12, 2014
First Posted
July 2, 2014
Study Start
March 1, 2014
Primary Completion
December 1, 2017
Study Completion
April 1, 2018
Last Updated
January 6, 2017
Record last verified: 2017-01